Close

News

ABEC Opens New Biopharmaceutical Manufacturing Facility in Wilson, North Carolina

ABEC is set to open a new manufacturing facility in Wilson, North Carolina, further strengthening its network of biopharmaceutical process equipment and consumables production. A ribbon-cutting ceremony to mark the occasion is scheduled for 24 September, with company leadership,...

UK Review Recommends ‘L Plates’ for New Healthcare AIs

The National Commission into the Regulation of AI in Healthcare has delivered its long-awaited report, setting out a framework for deploying artificial intelligence tools within the National Health Service in a manner described as "safe, fast, and trusted." Commissioned by...

Hengrui Wins World-First Approval for Hetrombopag in Chemotherapy-Induced Thrombocytopenia

Jiangsu Hengrui Pharma has secured a landmark regulatory clearance in China for its oral thrombopoietin (TPO) receptor agonist hetrombopag, making it the first oral TPO agonist anywhere in the world to receive approval for chemotherapy-induced thrombocytopenia (CIT). The approval...

Why FDA 510(k) Clearance and EU CE MDR Certification Should Anchor Your Hearing Aid Sourcing Strategy

Introduction For e-commerce platforms, hospital procurement directors, healthcare supply chain managers, and medical device importers, hearing aid sourcing has moved far beyond simple price-per-unit comparisons. The international medical device landscape now demands verifiable regulatory compliance, robust factory documentation, and data...

Gilead Sciences Inaugurates Advanced Research Centre in California

Gilead Sciences has expanded its R&D infrastructure with a new 182,000-square-foot facility in Foster City dedicated to inflammation, oncology, and data science.

Research Peptide Quality: What Laboratories Need to Know

Research Peptides in Modern Drug Discovery: Quality, Purity, and Sourcing Standards Peptides have been a part of research for many years. The way scientists handle peptides has changed a lot. New methods for making them, better tools to analyze them,...

Biomarkers, Second Opinion, and Immunotherapy Planning for Stage 4 Colon Cancer With Booking Health

In recent years, biomarkers have become an essential part of patient evaluation and are driving the overall therapeutic strategy. Accurate molecular profiling of the tumor before any intervention is an essential component of effective treatment planning for stage 4...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »